Immunization Update 2015

7/10/2015 8:00 AM - 11:00 AM

Presenter: Sharon Rush, R.Ph. & Nathan Pope, Pharm.D.

Texas Pharmacy Association (154) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Continuing education will be provided to participants who completed all course requirements.  

 

154-0000-15-034-L04-P

154-0000-15-034-L04-T

 

This lesson is an application-based CE activity and is targeted to pharmacists and technicians. This program has been accredited for 3.0 contact hours of continuing education credit (0.3 CEUs).

 

Description: This presentation will give immunizing pharmacists their full 3-hour CE credit and focus on updating them in the major aspects of immunizations. It will also familiarize the pharmacist with post-exposure treatment recommendations for vaccine preventable diseases. The program is designed to enhance learning through interactive tools such as Turning Point, clickers and hands-on administration technique.

 

At the completion of this activity, pharmacists and technicians will be able to:

1. Identify changes or updates to the immunization schedules for persons aged 0 through 18 years and adults based on January 2015
2. Evaluate the most current Advisory Committee on Immunization Practices (ACIP) recommendations
3. Evaluate various questions that have been submitted to the CDC website as well as self-submitted by participants.

Getting a Patient Involved in Change Talk: Motivational Interviewing

7/10/2015 2:45 PM - 4:15 PM

Presenter: Delaney Ivy, Pharm.D.

Texas Pharmacy Association (154) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Continuing education will be provided to participants who completed all course requirements.

 

0154-0000-15-035-L04-P

0154-0000-15-035-L04-T

 

This lesson is an application-based CE activity and is targeted to pharmacists and technicians. This program has been accredited for 1.5 contact hours of continuing education credit (0.15 CEUs).

 

Description: A diagnosis with a chronic disease state results in a patient typically needing to make many changes in their lifestyle including compliance with medications. In order to make these changes, patients need to develop their own motivation, and pharmacists can play a role in helping them find the motivation. This program will discuss the principles of motivational interviewing, and its role in eliciting change talk within a patient. By using these techniques, pharmacists can increase medication compliance, and help patients take control of their health.

 

At the completion of this activity, pharmacists will be able to:

1. Describe principles of motivational interviewing. 

2. Effectively use motivational interviewing techniques in patient counseling.

 

At the completion of this activity, technicians will be able to:

1. Describe principles of motivational interviewing. 

2. List motivational interviewing techniques in patient communication.

 

Sponsored by Capital Area Pharmacy Association

New and Emerging Interferon-free Treatments for Chronic Hepatitis C

7/10/2015 4:30 PM - 5:30 PM

Presenter: Rebecca Brady, Pharm.D. & Alireza FakhriRavari, Pharm.D.

Texas Pharmacy Association (154) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Continuing education will be provided to participants who completed all course requirements.  

  

0154-0000-15-037-L01-P

0154-0000-15-037-L01-T

 

This lesson is an application-based CE activity and is targeted to pharmacists and technicians. This program has been accredited for 1.5 contact hours of continuing education credit (0.15 CEUs).

 

Description: This program will educate the audience on the new direct acting anti-viral agents including the clinical evidence that has created a paradigm shift in the treatment efficacy and safety of chronic Hepatitis C Virus infection.

 

At the completion of this activity, pharmacists will be able to:

1. Recognize the pathogenesis and natural disease progression of hepatitis C.

2. Evaluate patient characteristics for appropriate screening and treatment selection.

3. Identify the key steps in the life cycle of hepatitis C virus (HCV).

4. Design an individualized treatment plan for HCV patients.

5. Develop a monitoring plan to assess clinical outcomes in HCV patients.

 

At the completion of this activity, technicians will be able to:

1. Describe the life cycle of HCV and its mechanism of chronic infection.

2. Evaluate patient characteristics for appropriate treatment selection.

3. Identify new and emerging direct-acting HCV treatments.

New Drug Update 2015

7/11/2015 7:30 AM - 9:00 AM

Presenter: Leroy Knodel, Pharm.D.

Texas Pharmacy Association (154) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Continuing education will be provided to participants who completed all course requirements.  

 

0154-0000-15-038-L01-P

0154-0000-15-038-L01-T

 

This lesson is a knowledge-based CE activity and is targeted to pharmacists and technicians. This program has been accredited for 1.5 contact hours of continuing education credit (0.15 CEUs).

 

Description: Every year the U.S. Food and Drug Administration approves a number of new drugs for use.  In some cases, these new agents represent significant advancements over older, more established treatments.  In other instances, however, marketing practices by pharmaceutical companies result in widespread use of some new drugs over less costly, commonly used agents with similar risks and benefits to patients. This seminar will review some recently approved drugs with an emphasis on their pharmacology, clinical efficacy, adverse effects, drug interactions, and monitoring requirements.  Attendees will learn practical information about the new drugs presented, which in turn, they can use in their interactions with prescribers and in the care and counseling of their patients.

 

At the completion of this activity, pharmacists will be able to:

1. Discuss the basic pharmacology of the new drugs presented and how the pharmacologic actions relate to both therapeutic and adverse effects.

2. Discuss clinically significant adverse effects and drug interactions, and the appropriate dosing and monitoring of the new drugs presented.

3. Discuss the therapeutic role of the new drugs presented as compared to agents already marketed.

 

At the completion of this activity, technicians will be able to:

1. List the new drugs presented.

2. Describe clinically significant adverse effects and drug interactions, and the appropriate dosing and monitoring of the new drugs presented.

Excursion - Blo Blow Dry Bar

7/11/2015 3:00 PM - 5:30 PM

Female attendees can feel “like a million bucks” on this excursion after having their hair professionally blow dried and styled.

Excursion - In the Kitchen with Chef Daniel

7/11/2015 3:00 PM - 5:30 PM

Excursion - Market Street Pub Beer Tasting

7/11/2015 3:00 PM - 5:30 PM

Excursion - Spa at The Waterway

7/11/2015 3:00 PM - 5:30 PM

Relax, unwind and be pampered!

Supportive Care During Cancer Treatment: The Pharmacist's Role

7/11/2015 3:15 PM - 5:15 PM

Presenter: Claire M. Mach, Pharm.D & Meghana Trivedi, Pharm.D.

Texas Pharmacy Association (154) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Continuing education will be provided to participants who completed all course requirements.  

  

0154-0000-15-040-L01-P

0154-0000-15-040-L01-T

 

This lesson is an application-based CE activity and is targeted to pharmacists and technicians. This program has been accredited for 2.0 contact hours of continuing education credit (0.2 CEUs).

 

Description: This program will provide pharmacists in various practice settings with information on essential topics related to the pharmacist's role in providing supportive care to meet the needs of patients during treatment of their cancer.

 

At the completion of this activity, pharmacists will be able to:

1. Discuss the most common supportive care needs of patients undergoing treatment of cancer.

2. Review current guidelines for management of supportive care needs of patients with cancer.

3. Identify useful patient education resources to enhance management of supportive care needs.

4. Design and deliver multidisciplinary care to prevent and treat cancer treatment-related symptoms and side effects to maximize quality of life of cancer patients.

 

At the completion of this activity, technicians will be able to:

1. Discuss the most common supportive care needs of patients undergoing treatment of cancer.

2. Review current guidelines for management of supportive care needs of patients with cancer.

3. Identify useful patient education resources to enhance management of supportive care needs.

Advances in Anticoagulation

7/12/2015 7:30 AM - 9:00 AM

Presenter: Laurajo Ryan, PharmD, MSc, BCPS, CDE

Texas Pharmacy Association (154) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Continuing education will be provided to participants who completed all course requirements.  

  

0154-0000-15-042-L01-P

0154-0000-15-042-L01-T

 

This lesson is an application-based CE activity and is targeted to pharmacists and technicians. This program has been accredited for 1.5 contact hours of continuing education credit (0.15 CEUs).

 

Description: This presentation highlights the recent developments in anticoagulation, and covers the differences in MOA, as well as recent safety controversies. Pharmacists must be aware of the dosing and safety guidelines to provide appropriate pharmaceutical care to their patients. The learner will be able to apply the content to providing accurate recommendations for dosing/safety of new anticoagulant agents.

 

At the completion of this activity, pharmacists will be able to:

1. List recent developments in anticoagulation therapy.

2. Apply the key prescribing points and safety concerns for new anticoagulants in patient care.

3. Propose options for reversal of new anticoagulants.

4. Evaluate patients transitioning between new anticoagulants to ensure patient safety.

 

At the completion of this activity, technicians will be able to:

1. Review recent developments in anticoagulation therapy.

2. List the key prescribing points and safety concerns for new anticoagulants.

Students as Pharmacist Extenders--Make Precepting a Win-Win for You and You

7/12/2015 8:00 AM - 11:00 AM

Texas Pharmacy Association (154) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Continuing education will be provided to participants who completed all course requirements.  

 

154-0000-15-048-L04-P

 

This lesson is an application-based CE activity and is targeted to pharmacists. This program has been accredited for 3.0 contact hours of continuing education credit (0.3 CEUs).

 

-- Literature Support Lisa Killam-Worrall, Pharm.D., UNT College of Pharmacy Students

 

-- as Pharmacist Extenders-- -- in the Ambulatory Care Setting Cesar Munoz, Pharm.D., BCPS, Harris Health System

 

-- in the Management Setting Carole Hardin-Oliver, R.Ph.

 

-- in MTM Vaidehi Bhatt, Pharm.D., Staff Pharmacist, CVS Caremark

 

At the completion of this activity, pharmacists will be able to:

1. Define the term "pharmacist extender"

2. Discuss the benefits and barriers to utilizing students as pharmacist extenders

3. Summarize the literature from utilizing students as pharmacist extenders

4. Develop new rotation models integrating learners into daily activities

5. Articulate the benefits of integrating learners into administrative or patient care duties

6. Explain the process for establishing common ground between student motivation and organizational goals. Preceptor

 

Education developed & co-sponsored by the Joint Committee On Internship Programs: Texas A&M Health Science Center Irma Lerma Rangel College of Pharmacy, Texas Southern University College of Pharmacy and Health Sciences, Texas Tech Health Science Center School of Pharmacy, The University of Texas at Austin College of Pharmacy, University of Houston College of Pharmacy, University of the Incarnate Word Feik School of Pharmacy.

Clarifying Dementia Disorientation

7/12/2015 10:30 AM - 11:30 AM

Presenter: Blair Sarbacker, Pharm.D.

Texas Pharmacy Association (154) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Continuing education will be provided to participants who completed all course requirements.  

 

0154-0000-15-045-L01-P

0154-0000-15-045-L01-T

 

This lesson is an application-based CE activity and is targeted to pharmacists and technicians. This program has been accredited for 1.0 contact hours of continuing education credit (0.1 CEUs).

 

Description: There is a lack of clarity about which drugs can potentiate dementia, as well as those that can induce delirium. Pharmacists will gain an understanding when these medications are indicated and the controversies surrounding them, allowing them to become better patient advocates. This presentation is a case-based seminar reviewing the types and treatments of dementia.

 

At the completion of this activity, pharmacists will be able to:

1. Differentiate between the most common types of dementia. 

2. Recommend the appropriate medications for dementia, based on the type and stage of dementia. 

3. When reviewing a medication list, identify drugs that can potentiate dementia or induce delirium in patients with dementia.

 

At the completion of this activity, technicians will be able to:

1. Differentiate between the most common types of dementia. 

2. List medications used in the treatment of dementia.